BMS-906024
CA216-001
Phase 1 small_molecule completed
Quick answer
BMS-906024 for Cancer is a Phase 1 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed